Table 5.
Treatment details of 277 patients with available systemic treatment records
| Treatment | No. of patients |
|---|---|
| Resectable disease | 69 |
| Surgery | 69 |
| Neoadjuvant therapy | 12a |
| Adjuvant therapy | 57b |
| Locally advanced and metastatic disease | 208 |
| Gemcitabine-based first-line treatment | 77c |
| 5-FU based combination | 126c |
| Best supportive care | 11 |
a
2 gemcitabine/oxaliplatin, 10 FOLFIRINOX.
b
33 gemcitabine, 9 FOLFIRINOX, 15 gemcitabine-based combinations.
c
22 with gemcitabine and nab-paclitaxel, 111 with FOLFIRINOX.